Corbus, Llc

Corbus, Llc company information, Employees & Contact Information

Explore related pages

Related company profiles:

We are the business solutions and transformation experts who clients turn to for innovative, agile solutions. Working with you, we quickly achieve business impact while driving momentum and creating sustainable value. As agents of change, our proven approach at Corbus enables you to solve your biggest business problems, make smarter decisions and achieve tomorrow's success through today's solutions and transformation. When you work with our team of experts, stationed around the world, you can rest assured they are singularly focused on bringing smart, break-through solutions that promote business momentum and success and allow you to focus on running your business. Our agility, expertise, and innovative, customized approach ensures we deliver the value you expect along with an exceptional experience. Headquartered in the Cincinnati-Dayton area, Corbus LLC is a global professional services and business consulting firm specializing in Supply Chain & Procurement Management; IT Technology & Solutions; Program, Project & Services Management; and Packaging & Prepress Technologies & Services. Founded in 1994, we are privately held by Soin International and a certified minority business enterprise. With our global delivery model including multi-lingual, multi-currency and multi-shore staffing options, we have the flexibility to meet your situation, requirements and culture. As a global team with people based in 20+ countries, we celebrate our diversity along with our similarities.

Company Details

Employees
503
Founded
-
Address
1129 Miamisburg Centerville Rd., West Carrollton,oh 45449,united States
Phone
888-608-9975
Email
hr****@****bus.com
Industry
Business Consulting And Services
NAICS
Management, Scientific, and Technical Consulting Services
Management Consulting Services
Other Scientific and Technical Consulting Services
Other Management Consulting Services
Website
corbus.com
HQ
West Carrollton, OH
Looking for a particular Corbus, Llc employee's phone or email?

Corbus, Llc Questions

News

Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium - GlobeNewswire

Corbus Pharmaceuticals to Participate in the Upcoming Piper Sandler Virtual Oncology Symposium GlobeNewswire

Oct 9 Fireside Chat 10:00AM ET — Corbus CEO Yuval Cohen to Present at Piper Sandler Virtual Oncology Symposium - Stock Titan

Oct 9 Fireside Chat 10:00AM ET — Corbus CEO Yuval Cohen to Present at Piper Sandler Virtual Oncology Symposium Stock Titan

Corbus Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides a Corporate Update - Yahoo Finance

Corbus Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides a Corporate Update Yahoo Finance

Corbus wins new FDA fast track tag for lead drug (CRBP:NASDAQ) - Seeking Alpha

Corbus wins new FDA fast track tag for lead drug (CRBP:NASDAQ) Seeking Alpha

Corbus Pharmaceuticals Receives FDA Fast Track for CRB-701 - TipRanks

Corbus Pharmaceuticals Receives FDA Fast Track for CRB-701 TipRanks

Corbus posts first US data on challenger to Pfizer’s ADC Padcev - Fierce Biotech

Corbus posts first US data on challenger to Pfizer’s ADC Padcev Fierce Biotech

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is largely controlled by institutional shareholders who own 51% of the company - Yahoo Finance

Corbus Pharmaceuticals Holdings, Inc. (NASDAQ:CRBP) is largely controlled by institutional shareholders who own 51% of the company Yahoo Finance

Corbus Advances 3 Clinical Programs: Obesity Drug Trial Expands, Cancer Data Coming to ESMO - Stock Titan

Corbus Advances 3 Clinical Programs: Obesity Drug Trial Expands, Cancer Data Coming to ESMO Stock Titan

Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data? - Seeking Alpha

Corbus Pharmaceuticals: Is Its Pipeline Really Worthless After Novo's Negative Data? Seeking Alpha

Corbus and GIS Announce Strategic Supply Chain and Procurement Partnership - PR Newswire

Corbus and GIS Announce Strategic Supply Chain and Procurement Partnership PR Newswire

ASCO-GU – Corbus throws its hat into the Nectin-4 ring | ApexOnco - Clinical Trials news and analysis - Oncology Pipeline

ASCO-GU – Corbus throws its hat into the Nectin-4 ring | ApexOnco - Clinical Trials news and analysis Oncology Pipeline

Corbus ADC data from Western study echoes China results, raising stakes for Padcev - FirstWord Pharma

Corbus ADC data from Western study echoes China results, raising stakes for Padcev FirstWord Pharma

Oppenheimer lowers Corbus Pharmaceuticals stock price target ahead of ESMO data - Investing.com

Oppenheimer lowers Corbus Pharmaceuticals stock price target ahead of ESMO data Investing.com

Corbus sees Novo’s controversial obesity approach as a ticket to a blockbuster - statnews.com

Corbus sees Novo’s controversial obesity approach as a ticket to a blockbuster statnews.com

Fred Corbus Obituary (2014) - Kalamazoo, MI - Kalamazoo Gazette - MLive.com

Fred Corbus Obituary (2014) - Kalamazoo, MI - Kalamazoo Gazette MLive.com

Corbus recognized as leader in procurement services; accepts top awards from ISG - PR Newswire

Corbus recognized as leader in procurement services; accepts top awards from ISG PR Newswire

Mizuho reiterates Outperform rating on Corbus stock ahead of ESMO data - Investing.com

Mizuho reiterates Outperform rating on Corbus stock ahead of ESMO data Investing.com

Corbus reports first Western data for closely tracked ADC cancer drug - statnews.com

Corbus reports first Western data for closely tracked ADC cancer drug statnews.com

FDA Grants Fast Track Designation to Corbus Pharmaceuticals’ Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma - Yahoo Finance

FDA Grants Fast Track Designation to Corbus Pharmaceuticals’ Nectin-4 Targeting ADC CRB-701 in Head and Neck Squamous Cell Carcinoma Yahoo Finance

Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate - Yahoo Finance

Corbus Pharmaceuticals Highlights Data From Its First US-Based Trial Of Lead Cancer Drug Candidate Yahoo Finance

Investors unsure on Corbus data for potential Padcev rival - The Pharma Letter

Investors unsure on Corbus data for potential Padcev rival The Pharma Letter

Corbus Pharmaceuticals Receives Second Fast Track Designation for CRB-701 and Announces Upcoming Presentation at ESMO 2025 - Quiver Quantitative

Corbus Pharmaceuticals Receives Second Fast Track Designation for CRB-701 and Announces Upcoming Presentation at ESMO 2025 Quiver Quantitative

Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) - PR Newswire

Corbus Pharmaceuticals expands oncology pipeline with the addition of a clinical stage Nectin-4 targeting Antibody Drug Conjugate (ADC) PR Newswire

We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate - Yahoo Finance

We're Not Very Worried About Corbus Pharmaceuticals Holdings' (NASDAQ:CRBP) Cash Burn Rate Yahoo Finance

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025 - GlobeNewswire

Corbus Pharmaceuticals to Present CRB-701 Phase 1/2 Data at ESMO 2025 GlobeNewswire

Corbus and CSPC Megalith sign licence agreement for antibody drug conjugate - Pharmaceutical Technology

Corbus and CSPC Megalith sign licence agreement for antibody drug conjugate Pharmaceutical Technology

Why Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? - Yahoo Finance

Why Is Corbus Pharmaceuticals Holdings, Inc. (CRBP) Among the Best Small-Cap Biotech Stocks With Massive Potential According to Hedge Funds? Yahoo Finance

On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev - Fierce Biotech

On the turnaround trail, tiny Corbus pays $7.5M for rival to Seagen's oncology ADC Padcev Fierce Biotech

167 Enrolled: Corbus CRB-701 Phase 1/2 Poster at ESMO 2025 with 122 Evaluable, HNSCC focus - Stock Titan

167 Enrolled: Corbus CRB-701 Phase 1/2 Poster at ESMO 2025 with 122 Evaluable, HNSCC focus Stock Titan

Corbus Relocates to The Exchange in Ohio - Supply & Demand Chain Executive

Corbus Relocates to The Exchange in Ohio Supply & Demand Chain Executive

Corbus tries to shift focus to early-stage pipeline as autoimmune treatment flunks another trial - Fierce Biotech

Corbus tries to shift focus to early-stage pipeline as autoimmune treatment flunks another trial Fierce Biotech

Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies - Seeking Alpha

Corbus Pharmaceuticals' Sell-Off: Speculative Entry Price In Oncology And Obesity Therapies Seeking Alpha

Is Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) In A Good Position To Deliver On Growth Plans? - simplywall.st

Is Corbus Pharmaceuticals Holdings (NASDAQ:CRBP) In A Good Position To Deliver On Growth Plans? simplywall.st

Corbus to ax half of staff after back-to-back trial failures - Fierce Biotech

Corbus to ax half of staff after back-to-back trial failures Fierce Biotech

Corbus Pharmaceuticals stock slips on drug data (CRBP:NASDAQ) - Seeking Alpha

Corbus Pharmaceuticals stock slips on drug data (CRBP:NASDAQ) Seeking Alpha

FDA Fast-Tracks Revolutionary Nectin-4 ADC: Corbus Pharma's CRB-701 Shows Promise in Head & Neck Cancer - Stock Titan

FDA Fast-Tracks Revolutionary Nectin-4 ADC: Corbus Pharma's CRB-701 Shows Promise in Head & Neck Cancer Stock Titan

Corbus Pharmaceuticals adds two mAbs to its pipeline - drugdiscoverytrends.com

Corbus Pharmaceuticals adds two mAbs to its pipeline drugdiscoverytrends.com

Obituary: James (Jimmy) L. Corbus (9/12/19) - Mountain Home News

Obituary: James (Jimmy) L. Corbus (9/12/19) Mountain Home News

Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference - Stock Titan

Corbus Pharmaceuticals to Present at the Jefferies London Healthcare Conference Stock Titan

‘Special’ day returns to Corbus Field - The Vacaville Reporter

‘Special’ day returns to Corbus Field The Vacaville Reporter

Why Is Corbus Pharmaceuticals (CRBP) Stock Up 300% Today? - InvestorPlace

Why Is Corbus Pharmaceuticals (CRBP) Stock Up 300% Today? InvestorPlace

Fred Corbus Obituary (2014) - Schoolcraft, MI - Kalamazoo Gazette - MLive.com

Fred Corbus Obituary (2014) - Schoolcraft, MI - Kalamazoo Gazette MLive.com

Corbus’ Lenabasum Fails Phase III Trial for Systemic Sclerosis - BioSpace

Corbus’ Lenabasum Fails Phase III Trial for Systemic Sclerosis BioSpace

Novo Dives — And Corbus Crashes — On Psychiatric Side Effects Of Weight-Loss Drug - Investor's Business Daily

Novo Dives — And Corbus Crashes — On Psychiatric Side Effects Of Weight-Loss Drug Investor's Business Daily

Corbus scores $25M from Cystic Fibrosis Foundation for 415-patient study - Fierce Biotech

Corbus scores $25M from Cystic Fibrosis Foundation for 415-patient study Fierce Biotech

Why Corbus Pharmaceuticals Is Getting Slammed Today - The Motley Fool

Why Corbus Pharmaceuticals Is Getting Slammed Today The Motley Fool

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2020 Earnings Call Transcript - The Motley Fool

Corbus Pharmaceuticals Holdings, Inc. (CRBP) Q4 2020 Earnings Call Transcript The Motley Fool

CRBP Stock Price and Chart — NASDAQ:CRBP - TradingView

CRBP Stock Price and Chart — NASDAQ:CRBP TradingView

Corbus Pharmaceuticals (CRBP) Stock Price, News & Analysis - MarketBeat

Corbus Pharmaceuticals (CRBP) Stock Price, News & Analysis MarketBeat

WEDDINGS; Elizabeth Hodder, Barclay Corbus (Published 1992) - The New York Times

WEDDINGS; Elizabeth Hodder, Barclay Corbus (Published 1992) The New York Times

Top Corbus, Llc Employees

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant